Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
40 results
D1.274 - Anaphylaxis Risks in Beekeeping: The Importance of Developing a Health Education Program
D1.284 - Trends in Recurrent Anaphylaxis Triggered by Food, Drug, and Insect Allergies from 2015 to 2021: A Population-Based Retrospective Cohort Study Using the National Insurance Claims Database of Japan
D1.275 - Wheat-free diet restore the normal intestinal microbiome structure in patients with wheat-dependent exercise-induced anaphylaxis
D1.276 - Social #anaphylaxis: how social media reveals shifting trends in public health concerns
D1.278 - Chlorhexidine allergy in perioperative anaphylaxis: undeclared and overlooked
D1.279 - Vit v 5: A Chitinase Implicated in Grape-Induced Anaphylaxis
D1.282 - Identification of Thaumatin-like protein (Ole E 13) as a potential allergen in green olives, a case report
D1.283 - Idiopathic anaphylaxis in a child, Alpha-gal syndrome. Is it an entity in children?
D1.285 - Analysis of systemic food reactions in patients sensitized to Bet v1 in Madrid (Spain)
D1.286 - Nebulized inhaled epinephrine versus epinephrine autoinjector for the treatment of food-induced anaphylaxis in young children – a randomized controlled clinical trial
D1.287 - Lipid profiling of Co-factor Induced Anaphylaxis: The Impact of Exercise and Aspirin on metabolism
D1.289 - Severe allergy to albumin after cesarean section
D2.294 - Allergic contact dermatitis unit at Hospital Joan XXIII (Tarragona, Spain): descriptive analysis 2022 - 2023
D2.295 - Characterization of Treatment-Refractory Chronic Urticaria: A Large-Scale Retrospective Analysis of Clinical and Laboratory Parameters
D2.296 - Allergic contact dermatitis caused by a oxybutynin in a transdermal patch
D2.297 - SEP-631: A Novel Selective and Potent Oral MRGPRX2 Inhibitor for the Treatment of Chronic Spontaneous Urticaria
D2.299 - A novel synthetic molecule LN49 suppressed oxidative stress and inflammation in skin epithelial and fibroblast cells via activating Nrf-2 signaling pathway
D2.300 - Fixed Drug Eruption related to the use of NSAIDs
D2.302 - Non - immediate hypersensitivity to oxybutynin, first confirmed case with lymphocyte transformation test
D2.303 - Blistering Discovery: A Rare Case of Toxic Epidermal Necrolysis Triggered by Carboplatin and Radiotherapy
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download